Hyperbaric oxygen therapy for acute idiopathic sudden sensorineural hearing loss; a systematic review with meta-analysis
There is moderate evidence that HBOT improves hearing when applied up to 30 days after the onset of ISSHL. HBOT in combination with steroids (oral or intra-tympanic) can be justified as a routine treatment. Future trials should address optimal dose and timing of HBOT and ensure outcomes enable pooling of data in future reviews, as well as addressing some measure of the functional significance of any improvement.
Authors
- Lorena Romero (ORCID: https://orcid.org/0000-0001-9884-5463)
- S. Sherlock (ORCID: https://orcid.org/0000-0002-3925-3086)
- Matthias Perleth (ORCID: https://orcid.org/0000-0001-5574-8356)
- Annemarie Newth (ORCID: https://orcid.org/0009-0004-5038-8944)
Institutions
- Gemeinsamer Bundesausschuss (DE)
- Prince of Wales Hospital (AU)
- Victoria Hospital (IN)
- St. Anna Hospital (DE)
- Alfred Health (AU)
Publication Details
- Journal
- Diving and Hyperbaric Medicine Journal
- Published
- 2025-12-09
- DOI
- https://doi.org/10.28920/dhm55.4.398-406
- Primary Topic
- Vestibular and auditory disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00